Tsinghua Changgeng Hospital, Beijing

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Hepatitis B2 trials
• Liver and biliary tract cancer1 trial

Phase

• Phase 32 trials
• Phase 1/21 trial

Status

• Completed1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Beijing Continent Pharmaceutical Co, Ltd.2 trials
• Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial

Running trials

• Recruiting

  A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

  NCT06431490· Phase 1/2· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Source

  Contact: Ming Yang, Doctor

• Recruiting

  Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis

  NCT05905172· Phase 3· Beijing Continent Pharmaceutical Co, Ltd.· Source

  Contact: Yuan Huang

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hepatitis B1 recruiting
• Liver and biliary tract cancer1 recruiting

Closed trials

• Completed

  Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.

  NCT05115942· Phase 3· Beijing Continent Pharmaceutical Co, Ltd.· Source